We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




New Gene Variant Linked to Prostate Cancer

By LabMedica International staff writers
Posted on 30 Jan 2018
Print article
Image: A diagram of the loss of an androgen-inactivating and isoform-specific HSD17B4 splice form enables emergence of castration-resistant prostate cancer (Photo courtesy of the Lerner Research Institute).
Image: A diagram of the loss of an androgen-inactivating and isoform-specific HSD17B4 splice form enables emergence of castration-resistant prostate cancer (Photo courtesy of the Lerner Research Institute).
Prostate cancer (PCa) is the most commonly diagnosed malignancy and the second leading cause of cancer-related death in men in the USA. The growth and survival of PCa cells are driven by androgens through activation of the androgen receptor (AR) and its target genes.

Androgen deprivation therapy (ADT), with medical or surgical castration, is the standard direct treatment for advanced PCa, but patients eventually relapse with progression to castration-resistant PCa (CRPC) and ultimately die of their disease.

Scientists at the Lerner Research Institute (Cleveland, OH, USA) have previously discovered that a gene called Hydroxy-Delta-5-Steroid Dehydrogenase, 3 Beta- And Steroid Delta-Isomerase 1(HSD3B1), when altered, enables prostate tumors to evade treatment and proliferate. They went on to show that the presence of this gene variant does in fact change treatment outcomes and overall survival in men. In a current study the team studied a related gene, called Hydroxysteroid 17-Beta Dehydrogenase 2, (HSD17B).

To determine HSD17B4's role in the transition to CRPC, the team analyzed its expression in tissue from patients with healthy prostates, localized prostate cancer and CRPC. Through a series of analyses including RNA Isolation and real-time polymerase chain reaction (qRT-PCR), the team used an ABI-7500 Real-Time PCR system, Western Blotting and Immunoprecipitation, Isoform Identification by LC-MS/MS Analysis using the Finnigan LTQ-Orbitrap Elite hybrid mass spectrometer system and other techniques were employed.

The scientists found that HSD17B4 expression levels were relatively the same in benign and local prostate cancer tissue, but significantly reduced in CRPC tissue, suggesting that HSD17B4 does play a role in preventing progression to CRPC. They found that only one specific isoform of HSD17B4, isoform 2, enzymatically inactivated androgens and prevented tumor growth. It is expressed during the early phases of prostate cancer, but is lost, or suppressed, in CRPC (advanced prostate cancer). Isoforms vary in amino acid sequence and physiological function, but not DNA code. The team also validated their findings in a preclinical model. Their findings suggest that lack of isoform 2 leads to advanced CRPC.

The authors concluded that their data bring clarity to what has generally been a perplexing link between HSD17B4 and the development of CRPC. When viewed through the lens of the enzymatic properties of a single specific isoform encoded by HSD17B4 variant 2, which is responsible for androgen inactivation, the functional expression of this variant transcript, its loss in the clinical development of CRPC, and its effects on in vivo CRPC growth, all concordantly point toward a causal role in the development of the lethal form of PCa. The study was published on January 16, 2018, in the journal Cell Reports.

Related Links:
Lerner Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.